We found that SIRPA, ATP2B1, RRBP1, SRRM2, SON, and RBM39 were significantly downregulated in NAFLD samples, while MAFB, CX3CR1, and DBI were significantly upgraded (Figure 5A). Here, DBI is linked to metabolic dysfunction-associated steatotic liver disease.